nach oben

Erschienen in:

18.02.2020 | Benigne Prostatahyperplasie | CME

Neue operative Techniken zur Therapie des benignen Prostatasyndroms

verfasst von: Dr. med. D. S. Schöb, A. C. Reichelt, Prof. Dr. med. A. J. Gross, PD Dr. D. Abt, Prof. Dr. Dr. med. univ. A. Miernik, FEBU, MHBA, Prof. Dr. med. C. Gratzke

Erschienen in: Die Urologie | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Zusammenfassung

In den letzten Jahren wurden neue operative Techniken zur Behandlung des benignen Prostatasyndroms (BPS) in die urologische Praxis eingeführt und in klinischen Studien evaluiert, mit denen Komplikationen der Standardverfahren (z. B. transurethrale Resektion der Prostata, TURP) vermieden und dennoch gleichwertige klinische Ergebnisse erzielt werden sollen. Im Vordergrund steht der Erhalt der erektilen Funktion und der antegraden Ejakulation. Außerdem sind ambulante Verfahren wünschenswert, die eine rasche Rekonvaleszenz ermöglichen. Diese Arbeit stellt Interventionsablauf, Wirkweise und aktuelle klinische Evidenz für neue mechanische Ansätze einer Desobstruktion, wassergestützte Ablationsverfahren und die Prostataarterienembolisation vor. Studienergebnisse deuten teilweise an, dass künftig nahezu jedem Patienten eine individualisierte Operationstechnik angeboten werden kann, die bei minimiertem Komplikationsrisiko eine optimale symptomatische und funktionelle Verbesserung mit sich bringt.

Berges RR, Pientka L (1999) Management of the BPH syndrome in Germany: who is treated and how? Eur Urol 36(Suppl 3):21–27CrossRef

Rohrmann S, Katzke V, Kaaks R (2016) Prevalence and progression of lower urinary tract symptoms in an aging population. Urology 95:158–163CrossRef

Bosch JL, Bangma CH, Groeneveld FP, Bohnen AM (2008) The long-term relationship between a real change in prostate volume and a significant change in lower urinary tract symptom severity in population-based men: the Krimpen study. Eur Urol 53(4):819–825 (discussion 25–7)CrossRef

Parsons JK, Wilt TJ, Wang PY, Barrett-Connor E, Bauer DC, Marshall LM (2010) Progression of lower urinary tract symptoms in older men: a community based study. J Urol 183(5):1915–1920CrossRef

Hong SJ, Rayford W, Valiquette L, Emberton M (2005) The importance of patient perception in the clinical assessment of benign prostatic hyperplasia and its management. BJU Int 95(1):15–19CrossRef

Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C et al (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099–1109CrossRef

Inc AUAEaR. American Urological Association Guideline: Management of Benign Prostatic Hyperplasia (BPH)Revised, 2010

Lu-Yao GL, Barry MJ, Chang C‑H, Wasson JH, Wennberg JE, Team PPOR (1994) Transurethral resection of the prostateamong medicare beneficiaries in the United States: time trends and outcomes. Urology 44(5):692–698CrossRef

Magistro G, Stief C, Gratzke C (2019) Neue minimal-invasive Therapie des benignen Prostatasyndroms. Urologe 58(3):254–262CrossRef

10.

Porpiglia F, Fiori C, Bertolo R, Garrou D, Cattaneo G, Amparore D (2015) Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up. BJU Int 116(2):278–287CrossRef

11.

Porpiglia F, Fiori C, Bertolo R, Giordano A, Checcucci E, Garrou D et al (2018) 3‑Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction. BJU Int 122(1):106–112CrossRef

12.

Porpiglia F, Fiori C, Amparore D, Kadner G, Manit A, Valerio M et al (2019) Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up. BJU Int 123(6):1061–1069CrossRef

13.

Amparore D, De Cillis S, Volpi G, Checcucci E, Manfredi M, Morra I et al (2019) First- and second-generation temporary Implantable nitinol devices as minimally invasive treatments for BPH-related LUTS: systematic review of the literature. Curr Urol Rep 20(8):47CrossRef

14.

Rukstalis D, Grier D, Stroup S, Tutrone R, deSouza E, Freedman S et al (2018) Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-018-0118-x CrossRefPubMedPubMedCentral

15.

Sievert KD, Schonthaler M, Berges R, Toomey P, Drager D, Herlemann A et al (2019) Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years. World J Urol 37(7):1353–1360CrossRef

16.

McAdams S, Funk JT, Navetta AF, El Tayeb MM, Humphreys MR (2017) Holmium laser enucleation of the prostate after prostatic urethral lift surgery: feasibility and technical considerations from a multi-institutional case series. J Endourol 31(8):774–779CrossRef

17.

Keehn A, Fram E, Garg M, Maria P (2017) Urolift in place of fiducial markers for patients with benign prostatic hyperplasia undergoing external beam radiation therapy. Urology 104:230–234CrossRef

18.

Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE et al (2013) The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol 190(6):2161–2167CrossRef

19.

Eure G, Gange S, Walter P, Khan A, Chabert C, Mueller T et al (2019) Real-world evidence of prostatic urethral lift confirms pivotal clinical study results: 2‑year outcomes of a retrospective multicenter study. J Endourol 33(7):576–584CrossRef

20.

Sonksen J, Barber NJ, Speakman MJ, Berges R, Wetterauer U, Greene D et al (2015) Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol 68(4):643–652CrossRef

21.

Gratzke C, Barber N, Speakman MJ, Berges R, Wetterauer U, Greene D et al (2017) Prostatic urethral lift vs transurethral resection of the prostate: 2‑year results of the BPH6 prospective, multicentre, randomized study. BJU Int 119(5):767–775CrossRef

22.

Dixon CM, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L et al (2016) Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia. Res Rep Urol 8:207–216PubMedPubMedCentral

23.

McVary KT, Rogers T, Roehrborn CG (2019) Rezum water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4‑year results from randomized controlled study. Urology 126:171–179CrossRef

24.

Mollengarden D, Goldberg K, Wong D, Roehrborn C (2018) Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience. Prostate Cancer Prostatic Dis 21(3):379–385CrossRef

25.

Darson MF, Alexander EE, Schiffman ZJ, Lewitton M, Light RA, Sutton MA et al (2017) Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezum system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Res Rep Urol 9:159–168PubMedPubMedCentral

26.

McVary KT, Rogers T, Mahon J, Gupta NK (2018) Is sexual function better preserved after water vapor thermal therapy or medical therapy for lower urinary tract symptoms due to benign prostatic Hyperplasia? J Sex Med 15(12):1728–1738CrossRef

27.

Magistro G, Stief CG, Gratzke C (2019) Neue minimal-invasive Therapie des benignen Prostatasyndroms. Urologe 58(3):254–262CrossRef

28.

Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T et al (2018) WATER: a double-blind, randomized, controlled trial of aquablation((R)) vs transurethral resection of the prostate in benign prostatic hyperplasia. J Urol 199(5):1252–1261CrossRef

29.

Gilling PJ, Barber N, Bidair M, Anderson P, Sutton M, Aho T et al (2019) Randomized controlled trial of aquablation versus transurethral resection of the prostate in benign prostatic hyperplasia: one-year outcomes. Urology 125:169–173CrossRef

30.

Bhojani N, Bidair M, Zorn KC, Trainer A, Arther A, Kramolowsky E et al (2019) Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results. Urology 129:1–7CrossRef

31.

Desai M, Bidair M, Zorn KC, Trainer A, Arther A, Kramolowsky E et al (2019) Aquablation for benign prostatic hyperplasia in large prostates (80–150 mL): 6‑month results from the WATER II trial. BJU Int 124(2):321–328CrossRef

32.

Carnevale FC, da Motta-Leal-Filho JM, Antunes AA, Baroni RH, Marcelino ASZ, Cerri LMO et al (2013) Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic Hyperplasia. J Vasc Interv Radiol 24(4):535–542CrossRef

33.

Laborda A, De Assis AM, Ioakeim I, Sánchez-Ballestín M, Carnevale FC, De Gregorio MA (2015) Radiodermitis after prostatic artery embolization: case report and review of the literature. Cardiovasc Intervent Radiol 38(3):755–759CrossRef

34.

Wang M, Guo L, Duan F, Yuan K, Zhang G, Li K et al (2016) Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates. BJU Int 117(1):155–164CrossRef

35.

Pisco JM, Rio Tinto H, Campos Pinheiro L, Bilhim T, Duarte M, Fernandes L et al (2013) Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol 23(9):2561–2572CrossRef

36.

Carnevale FC, Iscaife A, Yoshinaga EM, Moreira AM, Antunes AA, Srougi M (2016) Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis. Cardiovasc Intervent Radiol 39(1):44–52CrossRef

37.

Gao Y‑A, Huang Y, Zhang R, Yang Y‑D, Zhang Q, Hou M et al (2014) Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate—a prospective, randomized, and controlled clinical trial. Radiology 270(3):920–928CrossRef

38.

Abt D, Hechelhammer L, Müllhaupt G, Markart S, Güsewell S, Kessler TM et al (2018) Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ 361:k2338CrossRef

39.

Ray AF, Powell J, Speakman MJ, Longford NT, DasGupta R, Bryant T et al (2018) Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int 122(2):270–282CrossRef

40.

Russo GI, Kurbatov D, Sansalone S, Lepetukhin A, Dubsky S, Sitkin I et al (2015) Prostatic arterial embolization vs open prostatectomy: a 1‑year matched-pair analysis of functional outcomes and morbidities. Urology 86(2):343–348CrossRef

Titel: Neue operative Techniken zur Therapie des benignen Prostatasyndroms
verfasst von: Dr. med. D. S. Schöb
A. C. Reichelt
Prof. Dr. med. A. J. Gross
PD Dr. D. Abt
Prof. Dr. Dr. med. univ. A. Miernik, FEBU, MHBA
Prof. Dr. med. C. Gratzke
Publikationsdatum: 18.02.2020
Verlag: Springer Medizin
Schlagwörter: Benigne Prostatahyperplasie
Benigne Prostatahyperplasie
TURP
Erschienen in: Die Urologie / Ausgabe 3/2020
Print ISSN: 2731-7064
Elektronische ISSN: 2731-7072
DOI: https://doi.org/10.1007/s00120-020-01149-1

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Der „unkomplizierte“ Leistenhoden

Varikozele bei Kindern und Jugendlichen – wann konservativ, wann operativ?

HWI-Prophylaxe bei Kindern – diese Alternativen sind vielversprechend

GeSRU

Termine

Kinder- und Jugendurologie